These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 9497875

  • 1. The effect of an intravenous infusion of IGF-I and insulin on IGFBP-1, IGFBP-3, acid labile subunit, free and bound IGF-I, catecholamines and potassium in normal volunteers during an amino acid and glucose clamp.
    Russell-Jones DL, Umpleby AM, Shojaee-Moradie F, Boroujerdi MA, Jones RH, Baxter RC, Sönksen PH.
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):685-91. PubMed ID: 9497875
    [Abstract] [Full Text] [Related]

  • 2. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
    Cotterill AM, Mendel P, Holly JM, Timmins AG, Camacho-Hübner C, Hughes SC, Ross RM, Blum WF, Langford RM.
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
    [Abstract] [Full Text] [Related]

  • 3. Splanchnic exchange of insulin-like growth factor binding protein-1 (IGFBP-1), IGF-I and acid-labile subunit (ALS) during normo- and hyper-insulinaemia in healthy subjects.
    Fernqvist-Forbes E, Ekberg K, Lindgren BF, Brismar K.
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):327-32. PubMed ID: 10469012
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [Abstract] [Full Text] [Related]

  • 5. Suppression of endogenous insulin secretion regulates the rapid rise of insulin-like growth factor binding protein (IGFBP)-1 levels following acute hypoglycaemia.
    Cotterill AM, Holly JM, Amiel S, Wass JA.
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):633-9. PubMed ID: 7687525
    [Abstract] [Full Text] [Related]

  • 6. Effects of intravenous insulin-like growth factor-I and insulin administration on insulin-like growth factor-binding proteins in the ovine fetus.
    Shen WH, Yang X, Boyle DW, Lee WH, Liechty EA.
    J Endocrinol; 2001 Oct; 171(1):143-51. PubMed ID: 11572798
    [Abstract] [Full Text] [Related]

  • 7. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults.
    Aimaretti G, Colao A, Corneli G, Pivonello R, MacCario M, Morrison K, Pflaum CD, Strasburger CJ, Lombardi G, Ghigo E.
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):771-7. PubMed ID: 10619983
    [Abstract] [Full Text] [Related]

  • 8. The circulating IGF system and its relationship with 24-h glucose regulation and insulin sensitivity in healthy subjects.
    Frystyk J, Nyholm B, Skjaerbaek C, Baxter RC, Schmitz O, Ørskov H.
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):777-84. PubMed ID: 12780756
    [Abstract] [Full Text] [Related]

  • 9. Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.
    Lieberman SA, Bukar J, Chen SA, Celniker AC, Compton PG, Cook J, Albu J, Perlman AJ, Hoffman AR.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):30-6. PubMed ID: 1377706
    [Abstract] [Full Text] [Related]

  • 10. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [Abstract] [Full Text] [Related]

  • 11. Serum free IGF-I during a hyperinsulinemic clamp following 3 days of administration of IGF-I vs. saline.
    Frystyk J, Hussain M, Skjaerbaek C, Schmitz O, Christiansen JS, Froesch ER, Orskov H.
    Am J Physiol; 1997 Sep; 273(3 Pt 1):E507-13. PubMed ID: 9316439
    [Abstract] [Full Text] [Related]

  • 12. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF, Odar-Cederlöf I, Ericsson F, Brismar K.
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [Abstract] [Full Text] [Related]

  • 13. Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes.
    Attia N, Caprio S, Jones TW, Heptulla R, Holcombe J, Silver D, Sherwin RS, Tamborlane WV.
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2324-8. PubMed ID: 10404797
    [Abstract] [Full Text] [Related]

  • 14. Plasma insulin-like growth factors (IGFs), IGF-Binding proteins (IGFBPs), acid-labile subunit (ALS) and IGFBP-3 proteolysis in individuals with clinical characteristics of Sotos syndrome.
    de Boer L, Hoogerbrugge CM, van Doorn J, van Buul-Offers SC, Karperien M, Wit JM.
    J Pediatr Endocrinol Metab; 2004 Apr; 17(4):615-27. PubMed ID: 15198293
    [Abstract] [Full Text] [Related]

  • 15. Insulin infusion increases levels of free IGF-I and IGFBP-3 proteolytic activity in patients after surgery.
    Nygren J, Carlsson-Skwirut C, Brismar K, Thorell A, Ljungqvist O, Bang P.
    Am J Physiol Endocrinol Metab; 2001 Oct; 281(4):E736-41. PubMed ID: 11551849
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment.
    Spagnoli A, Chiarelli F, Vorwerk P, Boscherini B, Rosenfeld RG.
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):587-96. PubMed ID: 10594519
    [Abstract] [Full Text] [Related]

  • 17. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [Abstract] [Full Text] [Related]

  • 18. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans.
    Olivecrona H, Hilding A, Ekström C, Barle H, Nyberg B, Möller C, Delhanty PJ, Baxter RC, Angelin B, Ekström TJ, Tally M.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415
    [Abstract] [Full Text] [Related]

  • 19. Response of insulin-like growth factor (IGF)-binding protein-1 (IGFBP-1) and IGFBP-3 to IGF-I treatment in severe insulin resistance.
    Quin JD, Checkley A, Gallagher A, Jones J, MacCuish AC, Miell JP.
    J Endocrinol; 1994 Apr; 141(1):177-82. PubMed ID: 7516962
    [Abstract] [Full Text] [Related]

  • 20. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH, Gill MS, de A Barretto ES, Alcântara MR, Miraki-Moud F, Menezes CA, Souza AH, Martinelli CE, Pereira FA, Salvatori R, Levine MA, Shalet SM, Camacho-Hubner C, Clayton PE.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.